We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$14.4B
AUM Growth
+$3.17B
Cap. Flow
+$1.99B
Cap. Flow %
13.87%
Top 10 Hldgs %
75.34%
Holding
1,511
New
483
Increased
305
Reduced
301
Closed
405

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$92.1M
2
MSFT icon
Microsoft
MSFT
+$81.2M
3
NVDA icon
NVIDIA
NVDA
+$77.3M
4
LLY icon
Eli Lilly
LLY
+$27.2M
5
SPOT icon
Spotify
SPOT
+$27.1M

Sector Composition

Rank Sector Weight
1 Technology 2.53%
2 Financials 2.03%
3 Industrials 1.57%
4 Healthcare 1.55%
5 Communication Services 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
601
Allstate
ALL
$68.3B
$649K ﹤0.01%
3,422
+1,057
+45% +$188K
BMRN icon
602
BioMarin Pharmaceuticals
BMRN
$13.1B
$648K ﹤0.01%
+9,218
New +$771K
LSTR icon
603
Landstar System
LSTR
$6.12B
$646K ﹤0.01%
3,421
-5,476
-62% -$1.01M
IIPR icon
604
Innovative Industrial Properties
IIPR
$1.66B
$642K ﹤0.01%
+4,766
New +$580K
CHH icon
605
Choice Hotels
CHH
$4.64B
$638K ﹤0.01%
4,898
-4,943
-50% -$619K
GRMN
606
Garmin
GRMN
$60.4B
$634K ﹤0.01%
+3,603
New +$623K
DOX icon
607
Amdocs
DOX
$6.21B
$634K ﹤0.01%
7,250
-2,323
-24% -$196K
SSD icon
608
Simpson Manufacturing
SSD
$7.96B
$633K ﹤0.01%
3,312
-4,231
-56% -$760K
ALLE icon
609
Allegion
ALLE
$14.1B
$625K ﹤0.01%
4,286
-2,541
-37% -$336K
BBIO icon
610
BridgeBio Pharma
BBIO
$16.6B
$623K ﹤0.01%
24,482
+11,297
+86% +$297K
UE icon
611
Urban Edge Properties
UE
$2.71B
$619K ﹤0.01%
+28,947
New +$582K
GO icon
612
Grocery Outlet
GO
$964M
$616K ﹤0.01%
+35,088
New +$664K
ICUI icon
613
ICU Medical
ICUI
$4.59B
$612K ﹤0.01%
+3,358
New +$497K
CTSH icon
614
Cognizant
CTSH
$26.4B
$612K ﹤0.01%
7,928
-3,058
-28% -$228K
ZEUS
615
DELISTED
Olympic Steel
ZEUS
$611K ﹤0.01%
+15,667
New +$659K
FWRD icon
616
Forward Air
FWRD
$641M
$608K ﹤0.01%
+17,182
New +$488K
CPRT icon
617
Copart
CPRT
$27.3B
$607K ﹤0.01%
11,580
-35,243
-75% -$1.83M
RLI icon
618
RLI Corp
RLI
$5.79B
$606K ﹤0.01%
7,824
-7,822
-50% -$578K
CLDX icon
619
Celldex Therapeutics
CLDX
$3.35B
$606K ﹤0.01%
17,815
+6,870
+63% +$262K
BCRX icon
620
BioCryst Pharmaceuticals
BCRX
$2.45B
$604K ﹤0.01%
79,468
-14,999
-16% -$114K
ORI icon
621
Old Republic International
ORI
$10.2B
$601K ﹤0.01%
+16,980
New +$575K
STAA icon
622
STAAR Surgical
STAA
$1.25B
$600K ﹤0.01%
+16,154
New +$602K
VREX icon
623
Varex Imaging
VREX
$779M
$594K ﹤0.01%
+49,867
New +$635K
CVGW
624
DELISTED
Calavo Growers
CVGW
$593K ﹤0.01%
+20,792
New +$508K
SEM
625
DELISTED
Select Medical
SEM
$591K ﹤0.01%
+31,474
New +$603K

Similar funds

Brevan Howard Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Brevan Howard Capital Management held 1,511 positions worth $14.4B, up 28% from $11.2B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Brevan Howard Capital Management deployed $1.99B of net new capital in Q3 2024, opening 483 new positions and adding to 305 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,136,000 shares worth $98M.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was UnitedHealth, an estimated $21.4M trimmed.

  • Brevan Howard Capital Management's largest Q3 2024 buy was iShares MSCI Emerging Markets ETF: 2,136,000 shares worth $98M.
  • Brevan Howard Capital Management added most to Eli Lilly in Q3 2024, an estimated $27.2M increase.
  • Brevan Howard Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $21.4M.
  • Brevan Howard Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, selling an estimated $59M.
  • Brevan Howard Capital Management's ten largest holdings make up 75% of its $14.4B portfolio in Q3 2024.
  • Brevan Howard Capital Management opened 483 new positions and closed 405 in Q3 2024.
  • Brevan Howard Capital Management's portfolio value rose 28% quarter-over-quarter to $14.4B.

Based on Brevan Howard Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.